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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER9PharmacogeneticsDeepak Voora, Geoffrey S. Ginsburg
Pharmacogenetics uses genetic variation to identify subgroups of patients that may respond
differently to a certain medication. Three principle classes of pharmacogenetic markers have
emerged: 1) pharmacokinetic; 2) pharmacodynamic; and 3) underlying disease mechanism.
Voora and Ginsburg review the association data for the major pharmacogenetic variants
associated with commonly used cardiovascular medications: antiplatelet agents, warfarin,
statins, beta-blockers, diuretics, and antiarrhythmic drugs. While ongoing clinical trials will
determine if routine use of pharmacogenetic testing may be beneficial, the data today support
pharmacogenetic testing for certain variants on an individualized, case-by-case basis.CLINICAL RESEARCH CARDIAC ARREST21Long-Term Survival After Cardiac Arrest Higher With PCI and THFlorence Dumas, Lindsay White, Benjamin A. Stubbs, Alain Cariou, Thomas D. Rea
Patients with therapeutic hypothermia (TH) and/or, in particular, percutaneous coronary
intervention (PCI) resuscitated after out-of-hospital cardiac arrest (OHCA) can improve
survival to hospital discharge, but less is known about long-term prognosis. Dumas and
colleagues performed a cohort investigation of nearly 6,000 persons who received emergency
medical service-attempted resuscitation, 17% of whom were discharged alive from the
hospital. Of those discharged alive, PCI was performed in 38% and TH in 26%. The 5-year
survival was significantly higher in those treated with PCI (79% vs. 54%), and in those
treated with TH (78% vs. 60%) in this nonrandomized cohort with similar results after
multivariable adjustment. These findings suggest that both PCI and TH improve long-term
survival after OHCA.(continued on page A-21)
JULY 3, 2012 (continued) A-21SCARDIAC SURGERY28Improved 5-Year Patency With Radial Artery Compared to SVGsSaswata Deb, Eric A. Cohen, Steve K. Singh, Dai Une, Andreas Laupacis, Stephen E. Fremes,
for the RAPS Investigators
Deb and colleagues present their findings of radial and saphenous vein graft occlusion rates
5 years after coronary artery bypass surgery (CABG). A total of 510 patients undergoing
CABG, with 3-vessel disease were within-patient randomization; the radial artery was
randomized to either the right or circumflex territory, and a saphenous vein graft (SVG) was
used for the other territory. At a mean of 7.8 years after surgery, the frequency of functional
graft occlusion was lower in radial arteries compared with SVGs (12% vs. 20%). Radial artery
conduits are less likely than SVGs to be occluded more than 5 years after surgery.HEART FAILURE AND LVADs
36tudy Suggests That LVAD Patients
Should Not Be Status 1A for Heart TransplantationTodd Dardas, Nahush A. Mokadam, Francis Pagani, Keith Aaronson, Wayne C. Levy
Patients with left ventricular assist devices (LVAD) are historically given 30 days of elective
status 1A time. Dardas and colleagues analyzed the Scientific Registry of Transplant
Recipients database to determine if this still makes sense given the improved outcomes with
LVAD. Status 1A registrants supported with dual inotropes and right heart monitoring had a
higher risk of adverse events when compared to those supported with implanted LVADs
using elective 1A time. The odds of receiving a transplant were higher for those with
implanted LVADs (odds ratio: 1.5) compared with dual-inotrope and intra-aortic balloon
pump support. These results suggest that the historic allowance for 30 days of elective status
1A time after LVAD should be reconsidered given their comparably low risk of death or
being delisted because they are too ill.HEART FAILURE AND LVADs44Current Risk Scoring System for LVADs Needs RefinementJeffrey J. Teuteberg, Greg A. Ewald, Robert M. Adamson, Katherine Lietz, Leslie W. Miller,
Antone J. Tatooles, Robert L. Kormos, Kartik S. Sundareswaran, David J. Farrar, Joseph G. Rogers
The Destination Therapy Risk Score (DTRS) was developed from retrospective data for the
pulsatile-flow HeartMate XVE (Thoratec Corporation, Pleasanton, California) left ventricular
assist device (LVAD) implanted as destination therapy (DT). Teuteberg and colleagues tested
the utility of the DTRS for predicting 90-day in-hospital mortality, its original application,
and long-term mortality in patients receiving newer generation continuous flow LVADs. The
risk of 90-day mortality was more than 2-fold higher in subjects with a high DTRS (16)
compared with the low risk group. However, area under the receiver-operating characteristic
curve analysis showed only modest discriminatory ability. The DTRS was predictive of 2-year
survival in patients implanted for DT but not for bridge to transplantation. These data
suggest the need for a more contemporary risk assessment score.Editorial Comment: Sean P. Pinney, page 52
(continued on page A-22)
JULY 3, 2012 (continued) A-22HEART RHYTHM DISORDERS54Hybrid Thoracoscopic Surgical and Transvenous Catheter Ablation of AFLaurent Pison, Mark La Meir, Jurren van Opstal, Yuri Blaauw, Jos Maessen, Harry J. Crijns
The combination of a transvenous endocardial approach and a thoracoscopic epicardial
approach in a single atrial fibrillation (AF) ablation procedure has the potential to result in
better outcomes then either procedure alone. Pison and colleagues studied the feasibility,
safety, and clinical outcomes up to 1 year for 26 patients undergoing a combined
simultaneous thoracoscopic and transvenous AF ablation. There were no procedural
complications. In 23% of the patients, the epicardial lesions were not transmural, and
endocardial touch-up was necessary. A combined transvenous endocardial and thoracoscopic
epicardial ablation procedure for AF, is a feasible and safe procedure with a single-procedure
success rate of 83% at 1 year.Editorial Comment: Hugh Calkins, page 62PRE-CLINICAL RESEARCH PRE-CLINICAL RESEARCH64Porcine Model Compares Surgical Strategies for Tetralogy of FallotThierry Bove, Stefaan Bouchez, Stefan De Hert, Patrick Wouters, Filip De Somer, Daniel Devos,
Pamela Somers, Guido Van Nooten
Bove and colleagues developed an experimental model in growing pigs, to study the acute and
chronic physiological effects of surgical right ventricular outflow tract (RVOT) reconstruction.
In the pulmonary valve insufficiency (PI) group, an isolated pulmonary valve insufficiency was
created by excision of 1 pulmonary vein leaflet through a transverse pulmonary arteriotomy.
In the infundibular dysfunction (INF) group, INF was obtained by infundibulotomy and
closure with a polytetrafluorethylene patch. The transannular patch (TAP) third group, had
both interventions. In animals with PI, pulmonary regurgitant fraction progressed more in
presence of concomitant INF with higher rates of decreased ejection fraction after 3 months.
Systolic indices showed acute impairment of right ventricular contractility in all treatment
groups, but more in animals with infundibular scarring (INF and TAP). These findings
support the adoption of a RVOT-sparing strategy to treat tetralogy of Fallot.EDITORIALS AND VIEWPOINTS72News From the NHLBIMichael S. Lauer
While mistaking randomness for cohesive stories may seem innocent enough when talking
about professional basketball, Tversky’s analysis revealed a truth about human psychology that
has far reaching implications. People are resistant to ascribe unexpected observations to
random chance and much prefer to tell stories.
